1. COPD biomarkers as tools for decision making in early clinical drug development. (May 2016) Authors: Taib, Ziad; Jauhiainen, Alexandra Journal: Biomarkers in medicine Issue: Volume 10:Number 5(2016) Page Start: 513 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effects of a selective glucocorticoid receptor modulator (AZD9567) versus prednisolone in healthy volunteers: two phase 1, single-blind, randomised controlled trials. (January 2020) Authors: Hegelund Myrbäck, Tove; Prothon, Susanne; Edman, Karl; Leander, Jacob; Hashemi, Mahdi; Dearman, Matthew; Edenro, Goran; Svanberg, Petter; Andersson, Eva-Marie; Almquist, Joachim; Ämmälä, Carina; Hendrickx, Ramon; Taib, Ziad; Johansson, Kicki A; Berggren, Anders R; Keen, Christina M; Eriksson, Ulf... Journal: Lancet Issue: Volume 2:Number 1(2020) Page Start: e31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and Tolerability of an Inhaled Selective Glucocorticoid Receptor Modulator – AZD5423 – in Chronic Obstructive Pulmonary Disease Patients: Phase II Study Results. Issue 4 (17th July 2017) Authors: Kuna, Piotr; Aurivillius, Magnus; Jorup, Carin; Prothon, Susanne; Taib, Ziad; Edsbäcker, Staffan Journal: Basic & clinical pharmacology & toxicology Issue: Volume 121:Issue 4(2017) Page Start: 279 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗